熱門資訊> 正文
ReShape Lifesciences公开募股定价260万美元
2025-06-10 00:18
- ReShape Lifesciences (NASDAQ:RSLS) on Monday announced the pricing of its public offering of 1.05M shares of common stock at a public offering price of $2.50 per share for gross proceeds of about $2.6M.
- The offering is expected to close on or about June 9, 2025, subject to the satisfaction of customary closing conditions.
- RSLS is -38.27% to $2.58.
- Source: Press Release
More on ReShape Lifesciences
- Financial information for ReShape Lifesciences
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
